Examination of the cancer genomic profiling test using bile cell block specimens and bile cytology specimens in malignant biliary tract disease

Examination of the cancer genomic profiling test using bile cell block specimens and bile cytology specimens in malignant biliary tract disease - Examination of the cancer genomic profiling test using bile cell block specimens and bile cytology specimens in malignant biliary tract disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049618

Enrollment

Registered

2022-12-01

Start date

2022-11-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant biliary stricture

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age > 19 years The patients who was able to place ENBD or PTBD, and collect bile for cytology and cell block method The case with written informed consent for participation

Exclusion criteria

Exclusion criteria: The patients who was not able to place ENBD or PTBD The patients who were already diagnosed cytologically or histologically before this study The patients who are otherwise judged by the investigator to be ineligible to participate in the study

Design outcomes

Primary

Measure	Time frame
Success rate and accuracy of cancer gene analysis using bile samples	—

Secondary

Measure	Time frame
Quantity and quality of DNA The relationship between cancer gene analysis and anticancer drug Factors for accurate cancer gene analysis	—

Countries

Japan

Contacts

Public ContactMitsuru Okuno

Gifu Municipal Hospital Department of Gastroenterology

mkobdkl@yahoo.co.jp058-251-1101

Outcome results